Johns Hopkins Research Reveals Hydrogen Sulfide-Producing Protein May Hold Key to Alzheimer's Treatment
Key Takeaways
- ▸CSE protein, which produces hydrogen sulfide, is essential for memory formation and cognitive function in the brain
- ▸Mice lacking CSE developed progressive memory loss and cellular changes consistent with Alzheimer's disease pathology
- ▸Scientists are exploring how to safely maintain naturally occurring trace levels of hydrogen sulfide to protect neurons without toxicity
Summary
Researchers at Johns Hopkins Medicine have discovered that a protein called Cystathionine γ-lyase (CSE), which produces trace amounts of hydrogen sulfide, plays a critical role in memory formation and brain health. The study, funded by the National Institutes of Health and published in the Proceedings of the National Academy of Sciences, found that mice genetically engineered to lack the CSE enzyme developed memory problems and exhibited hallmark features of Alzheimer's disease, including increased oxidative stress, DNA damage, and weakened blood-brain barrier integrity.
The research builds on a decade of work by Johns Hopkins scientists, including emeritus professor Solomon Snyder, who previously linked CSE to brain protection in mice with Huntington's disease and Alzheimer's disease. The team used behavioral tests such as the Barnes maze to demonstrate that CSE-deficient mice showed progressive memory decline by six months of age, while normal mice maintained spatial memory abilities. While hydrogen sulfide is toxic in large quantities, scientists are investigating how to safely leverage the naturally occurring trace amounts in neurons to develop new treatment approaches for neurodegenerative diseases.
- The findings suggest CSE activity could represent a new therapeutic target for Alzheimer's and other neurodegenerative diseases
Editorial Opinion
This research represents an intriguing shift in neurodegenerative disease research by focusing on an unconventional biomarker—a gas traditionally associated with unpleasant odors. The decade-long progression of this work demonstrates the value of sustained basic research in identifying novel therapeutic pathways that might have been dismissed by less thorough investigation. However, the critical challenge ahead lies in translation: safely delivering or enhancing CSE activity in human brains without triggering the toxicity concerns that make direct hydrogen sulfide administration impractical.
